| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | -235.74K | 0.00 | -1.04M | -752.33K | -528.00K | -163.00K |
| Net Income | -335.04K | -656.50K | -1.21M | -961.29K | -693.00K | -329.00K |
Balance Sheet | ||||||
| Total Assets | 18.23M | 18.63M | 18.86M | 18.83M | 19.04M | 20.73M |
| Cash, Cash Equivalents and Short-Term Investments | 43.79K | 44.26K | 219.69K | 247.13K | 922.18K | 891.77K |
| Total Debt | 4.23M | 4.05M | 3.91M | 4.19M | 4.31M | 4.15M |
| Total Liabilities | 4.73M | 4.36M | 4.37M | 4.45M | 4.72M | 4.32M |
| Stockholders Equity | 13.50M | 14.27M | 14.49M | 14.38M | 14.32M | 16.41M |
Cash Flow | ||||||
| Free Cash Flow | -52.57K | -723.72K | -1.27M | -1.29M | -707.85K | -251.66K |
| Operating Cash Flow | -52.51K | -393.02K | -775.96K | -794.19K | -388.17K | -174.04K |
| Investing Cash Flow | -104.06K | -330.28K | -496.50K | -586.12K | -319.68K | -97.67K |
| Financing Cash Flow | 109.38K | 547.92K | 1.25M | 705.11K | 738.23K | 1.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | £7.79M | -3.57 | -67.90% | ― | ― | ― | |
48 Neutral | £4.77M | -1.28 | -44.38% | ― | 1.77% | 33.33% | |
45 Neutral | £3.56M | -2.34 | -25.13% | ― | ― | ― | |
43 Neutral | £3.69M | -0.78 | -44.29% | ― | ― | ― | |
42 Neutral | £3.40M | -1.08 | -4.75% | ― | ― | 36.36% | |
| ― | £2.51M | -0.32 | ― | ― | ― | 17.65% |